What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Disease
Hypertrophic cardiomyopathy, Sudden death, Internal medicine, Cardiology and Genetic testing are his primary areas of study.
His studies in Hypertrophic cardiomyopathy integrate themes in fields like Cardiomyopathy, Heart failure, Phenotype, Gene and Gene mutation.
His work deals with themes such as Genetics, Anxiety, Heart disease, Sudden cardiac death and Depression, which intersect with Sudden death.
His work carried out in the field of Genetics brings together such families of science as Disease and Bioinformatics.
Christopher Semsarian studies Internal medicine, namely Muscle hypertrophy.
Genetic variants and Computational biology is closely connected to MEDLINE in his research, which is encompassed under the umbrella topic of Cardiology.
His most cited work include:
- HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA) (1076 citations)
- Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy (645 citations)
- HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies (568 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Hypertrophic cardiomyopathy, Cardiology, Sudden cardiac death and Cardiomyopathy.
His Internal medicine study frequently involves adjacent topics like Endocrinology.
His Hypertrophic cardiomyopathy research is multidisciplinary, incorporating elements of Genetics, Genetic testing, Heart failure, Phenotype and Gene mutation.
He has researched Sudden cardiac death in several fields, including Implantable cardioverter-defibrillator, Cause of death, Intensive care medicine, Athletes and Pediatrics.
The study incorporates disciplines such as Troponin I, Left ventricular hypertrophy, Mutation, Pathology and Dilated cardiomyopathy in addition to Cardiomyopathy.
Christopher Semsarian has included themes like Coronary artery disease and Psychiatry in his Sudden death study.
He most often published in these fields:
- Internal medicine (99.72%)
- Hypertrophic cardiomyopathy (81.82%)
- Cardiology (80.30%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (99.72%)
- Cardiology (80.30%)
- Hypertrophic cardiomyopathy (81.82%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Internal medicine, Cardiology, Hypertrophic cardiomyopathy, Genetic testing and Sudden cardiac death.
His biological study spans a wide range of topics, including Interquartile range, Catecholaminergic polymorphic ventricular tachycardia, Athletes, Asymptomatic and Cardiac magnetic resonance.
His work deals with themes such as Heart failure, Phenotype, Guideline, Long QT syndrome and Atrial fibrillation, which intersect with Hypertrophic cardiomyopathy.
Genetic testing is a subfield of Genetics that Christopher Semsarian studies.
In his study, which falls under the umbrella issue of Sudden cardiac death, Epidemiology is strongly linked to Sudden cardiac arrest.
His research integrates issues of Ventricle, Computational biology and Sudden death in his study of Disease.
Between 2019 and 2021, his most popular works were:
- A systematic review and meta-analysis of the prevalence of left ventricular non-compaction in adults. (35 citations)
- Genetic Testing for Inherited Cardiovascular Diseases: A Scientific Statement From the American Heart Association. (26 citations)
- 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines (24 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Disease
Christopher Semsarian mainly investigates Hypertrophic cardiomyopathy, Internal medicine, Cardiomyopathy, Sudden cardiac death and Cardiology.
His work carried out in the field of Hypertrophic cardiomyopathy brings together such families of science as Genetics, Heart failure, Phenotype, Guideline and Atrial fibrillation.
His Cardiomyopathy research incorporates elements of Missense mutation, Bioinformatics, Long QT syndrome, Heart disease and Genetic testing.
His Sudden cardiac death study combines topics in areas such as ATP1A3, Young adult, Primary prevention, Family medicine and Evidence-based medicine.
His Cardiology research is multidisciplinary, incorporating perspectives in Cerebellar ataxia and Alternating hemiplegia of childhood.
His research investigates the link between Implantable cardioverter-defibrillator and topics such as Risk stratification that cross with problems in Sudden death.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
